Pharmiva Balance Sheet Health
Financial Health criteria checks 4/6
Pharmiva has a total shareholder equity of SEK15.5M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK19.4M and SEK3.9M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr4.94m |
Equity | kr15.45m |
Total liabilities | kr3.92m |
Total assets | kr19.37m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHARM's short term assets (SEK7.6M) exceed its short term liabilities (SEK3.9M).
Long Term Liabilities: PHARM has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: PHARM is debt free.
Reducing Debt: PHARM has no debt compared to 5 years ago when its debt to equity ratio was 18.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PHARM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PHARM has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.1% each year